Table 10 Multinomial logistic analysis showing correlation between urogenital schistosomiasis and behavioural factors (knowledge of infection and attitude to treatment) (N = 470)

Knowledge of urogenital schistosomiasis and source of knowledge

No

211 (44.9)

21 (10.0)

3.701(1.509–9.076)

0.004^S

School

162 (34.5)

26 (16.0)

2.140(0.886–5.168)

0.091^NS

Church

38 (8.0)

5 (13.20)

2.700(0.798–9.137)

0.110^NS

Mass media

28 (6.0)

7 (25.0)

1.227(0.387–3.894)

0.728^NS

Mass Administration Medicines^a

31 (6.6)

9 (29.0)

1.000

Knowledge of female genital schistosomiasis

No

448 (95.3)

62 (13.8)

2.335 (0.880–6.195)

0.089^NS

Yes^a

22 (4.7)

6 (27.3)

1.000

Knowledge of transmission of urogenital schistosomiasis

No idea

454 (96.6)

65 (14.3)

2.565(0.647–10.172)

0.180^NS

Vector borne route

4 (0.9)

0 (0.0)

X

X

Oral-faecal route

2 (0.4)

0 (0.0)

X

X

Skin penetration^a

10 (2.1)

3 (30.0)

1.000

Knowledge of transmission of female genital schistosomiasis

No idea

461 (98.1)

65 (14.1)

9.138 (1.498–55.746)

0.016^S

Vector borne route

4 (0.9)

0 (0.0)

X

X

Oral-faecal route^a

5 (1.0)

3 (60.0)

1.000

Treatment with Praziquantel and where it was administered

No answer

161 (34.2)

29 (18.0)

0.845(0.413–1.729)

0.645^NS

Over the counter

196 (41.7)

19 (9.7)

1.730(0.811–3.691)

0.156^NS

Hospital

30 (6.4)

7 (23.3)

0.610(0.217–1.714)

0.348^NS

Mass Administration of Medicines^a

83 (17.7)

13 (15.70)

1.000

Duration of last deworming

No answer

10 (2.1)

0 (0.0)

X

X

1–3 months

39 (8.3)

5 (12.8)

1.040 (0.388–2.784)

0.938^NS

4–6 months

44 (9.4)

13 (29.5)

0.365 (0.179–0.744)

0.006^S

Above 6 months^a

377 (80.2)

50 (13.3)

1.000

Individual who administered the medicine

No answer

72 (15.3)

16 (22.2)

0.496 (0.236–1.043)

0.064^NS

Family member

253 (53.8)

34 (13.4)

0.913 (0.495–1.683)

0.770^NS

Health practitioner^a

145 (30.9)

18 (12.4)

1.000

Compliance with height-based dosage

No

257 (54.7)

42 (16.3)

0.602 (0.203–1.787)

0.361^NS

Yes

175 (37.2)

22(12.6)

0.818 (0.265–2.529)

0.727^NS

Not sure^a

38 (8.1)

4 (10.5)

1.000

Comfort level discussing genital health challenges

Not comfortable

116 (24.7)

21 (18.1)

0.251 (0.083–0.764)

0.015^S

Very comfortable

278 (59.1)

43 (15.5)

0.304 (0.105–0.875)

0.027^S

Somewhat comfortable^a

76 (16.2)

4 (5.3)

1.000

Preferred individual for discussing such issues

Family member

305 (64.9)

40 (13.1)

1.237 (0.639–2.394)

0.528^NS

Sibling

46 (9.8)

3 (6.5)

2.676 (0.728–9.838)

0.139^NS

Friend

23 (4.9)

9 (39.1)

0.290 (0.105–0.800)

0.017^S

Teacher

7(1.5)

2 (28.6)

0.467 (0.082–2.649)

0.390^NS

Health practitioner^a

89 (18.9)

14 (15.7)

1.000

Importance of prevention and treatment of urogenital schistosomiasis

Not important

9 (1.9)

0 (0.0)

X

X

Very important

356 (75.7)

56 (15.7)

0.691 (0.355–1.345)

0.277^NS

Somewhat important^a

105 (22.4)

12 (11.4)

1.000

Importance of prevention and treatment of female genital schistosomiasis

Not important

9 (1.9)

0 (0.0)

X

X

Very important

356 (75.7)

58 (16.3)

0.541 (0.266–1.100)

0.090^NS

Somewhat important^a

105 (22.4)

10 (9.5)

1.000